SINGAPORE (Apr 1): RHB is keeping its “buy” recommendation on TalkMed with a lowered target price of 53 cents from 62 cents previously.

With the ongoing travel restrictions in place due to the Covid-19 outbreak, TalkMed will be seeing a drop in the number of medical tourists, as international visitors are not allowed to enter Singapore for short-term trips.

This resulted in a halt of foreign medical tourism, especially those from Indonesia, which is the bulk of the group’s portfolio.

To continue reading,

Sign in to access this Premium article.

Subscription entitlements:

Less than $9 per month
3 Simultaneous logins across all devices
Unlimited access to latest and premium articles
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook